Comparison of IV Nalbuphine Versus Ibuprofen for Postoperative Pain Control in Cesarean Section
Not Applicable
Completed
- Conditions
- Pain Management
- Registration Number
- NCT06594224
- Lead Sponsor
- Muhammad Aamir Latif
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
Inclusion Criteria:<br><br> - Parturient females<br><br> - Aged between 18-45 years<br><br> - Gestational age above 32 weeks<br><br> - ASA class I to II<br><br> - Anticipated hospital stay for at least 24 hours<br><br>Exclusion Criteria:<br><br> - Known allergy to the drugs being evaluated in this study<br><br> - Renal and/or hepatic impairment (as per medical record)<br><br> - History of bronchial asthma or history or risk of intracranial hemorrhage (as per<br> medical record)<br><br> - Low platelets count (<70000) or with bleeding diathesis<br><br> - BMI above 30 kg/m2
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy in pain control
- Secondary Outcome Measures
Name Time Method